Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Auxilium Pharmaceuticals,
Develops and markets pharmaceutical products

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.

It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons.

The company currently markets two products in the United States: Testim testosterone gel and XIAFLEX.

The Testim testosterone gel is a proprietary, topical testosterone once-a-day gel indicated for the treatment of hypogonadism.

The XIAFLEX is a proprietary, injectable collagenase enzyme approved by the United States Food and Drug Administration for the treatment of Dupuytren's contracture in adult patients with a palpable cord.

Auxilium Pharmaceuticals was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products395.28100%400.72100% +1.36%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States288.6273%378.1894.4% +23.68%
International106.6727%22.545.6% -373.27%
Officers and Executives
NameAgeOfficer SinceTitle
Adrian Adams63-President, Chief Executive Officer & Director
Rolf A. Classon69-Chairman
James E. Fickenscher, CPA50-Chief Financial Officer & Head-Investor Relations
James Patrick Tursi, MD49-Chief Medical Officer
William T. McKee52-Independent Director
Paul A. Friedman, MD71-Independent Director
Peter C. Brandt, MBA57-Independent Director
Nancy Sue Lurker, MBA55-Independent Director
Oliver Steffen Fetzer PhD, MBA49-Independent Director
William Q. Sargent Jr., MBA--VP-Investor Relations & Corporate Communications
Surperformance© rating of Auxilium Pharmaceuticals,
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER - - -
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Advertisement
Sector Pharmaceuticals - Diversified
Trading RatingInvestor Rating
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
Sector Pharmaceuticals - Diversified
Company contact information
Auxilium Pharmaceuticals, Inc.
640 Lee Road
Chesterbrook, PA 19087

Phone : +1.484.321.5900
Fax : +1.484.321.5999
Web : www.auxilium.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF